Showing results (101-110 of 458) with videos related to
Sort By:
Pageof 46
Biomarker Insights|February 24, 2025
Endothelin-1 as a Candidate Biomarker of Systemic Sclerosis: A GRADE-Assessed Systematic Review and Meta-Analysis With Meta-RegressionArduino A Mangoni, Angelo ZinelluBiomarker Insights|January 13, 2025
Differentiating Latent Tuberculosis from Active Tuberculosis Through Activation Phenotypes and Chemokine Markers HLA-DR, CD38, MCP-1, and RANTES: A Systematic Review and Meta-AnalysisChaimae Kadi, Narjisse Ahmadi, Anass Houdou, et al.Biomarker Insights|November 19, 2024
Procalcitonin Guided Antibiotic StewardshipGirum Tesfaye Kiya, Elsah Tegene Asefa, Gemeda Abebe, et al.Biomarker Insights|June 12, 2024
Association of 10 Polymorphisms in PLA2R1 and HLA DQA1 Genes with Primary Membranous Nephropathy Risk: A Meta-Analysis and a Meta-RegressionTarak Dhaouadi, Awatef Riahi, Taïeb Ben Abdallah, et al.Biomarker Insights|June 18, 2024
Genetic Association Between Polycystic Ovary Syndrome and the APOA5 rs662799 and PLIN1 rs894160 Metabolic Variants in the Western Saudi Population: A Case-Control StudySherin Bakhashab, Asma A Batarfi, Mahinar M Alhartani, et al.Biomarker Insights|May 6, 2024
Comparative Analysis of Biomarkers in Type 2 Diabetes Patients With and Without Comorbidities: Insights Into the Role of Hypertension and Cardiovascular DiseaseSymeon Savvopoulos, Haralampos Hatzikirou, Herbert F JelinekBiomarker Insights|March 7, 2022
Decrease in Plasma miR-27a and miR-221 After Concussion in Australian Football PlayersSandy R Shultz, Caroline J Taylor, Riemke Aggio-Bruce, et al.Biomarker Insights|February 17, 2022
Mind Over Matter: Confronting Challenges in Post-Mortem Brain Biobanking for Glioblastoma MultiformeCassandra Griffin, Ricardo Vilain, Simon King, et al.Biomarker Insights|September 17, 2019
Serum Potassium, Sodium, and Chloride Levels in Sickle Cell Disease Patients and Healthy Controls: A Case-Control Study at Korle-Bu Teaching Hospital, AccraCharles Antwi-Boasiako, Yaw A Kusi-Mensah, Charles Hayfron-Benjamin, et al.Biomarker Insights|October 21, 2015
More than a Decade of Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors: What We Have Learned and What the Future HoldsMaria VergoulidouPageof 46